SECsense Logo

Citius Oncology, Inc. 8-K Report: Key Insights from December 27, 2024 Filing

$CTOR
Form 8-K
Filed on: 2024-12-27
Source
Citius Oncology, Inc. 8-K Report: Key Insights from December 27, 2024 Filing

Based on the extracted XML section from the financial report, here are the key insights:

  1. Entity Information:
  • Company Name: Citius Oncology, Inc.
  • CIK Number: 0001851484
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-41534
  • EIN: 99-4362660
  • Address: 11 Commerce Drive, 1st Floor, Cranford, NJ 07016
  • Contact Number: 908-967-6677
  1. Filing Details:
  • Filing Type: 8-K (current report)
  • Filing Date: December 27, 2024
  1. Stock Information:
  • Common Stock Symbol: CTOR
  • Exchange: NASDAQ
  1. Reporting Context:
  • Reporting Date: December 27, 2024
  • Period: The report covers a single day, indicating it is likely addressing a specific event or change relevant to that date.
  1. Units of Measurement:
  • The report uses USD (United States Dollar) for monetary values and shares for equity measurements.

Summary:

Citius Oncology, Inc. has filed an 8-K report with the SEC on December 27, 2024, indicating a potentially significant event or development. The company is listed on NASDAQ under the ticker CTOR, and it is based in Cranford, New Jersey. This filing may provide further insights into corporate actions, financial performance, or other material events impacting the company's stock and operations.